GSC The List

Post Reply

[email protected]
Site Owner
Posts: 1174

Cannabinoid–Dopamine Interaction in the Pathophysiology and Treatment of CNS Disorders (full – 2010) http/

Enhancement of endocannabinoid signaling by fatty acid amide hydrolase inhibition: a neuroprotective therapeutic modality. (full – 2010) http/

Loss of cannabinoid CB1 receptor expression in the 6-hydroxydopamine-induced nigrostriatal terminal lesion model of Parkinson's disease in the rat. (full – 2010) http/

Cannabinoids and Dementia: A Review of Clinical and Preclinical Data (link to PDF – 2010) http/

Cannabinoid receptor agonist protects cultured dopaminergic neurons from the death by the proteasomal dysfunction. (full – 2011) http/

Is lipid signaling through cannabinoid 2 receptors part of a protective system? (full – 2011) http/

Prospects for cannabinoid therapies in basal ganglia disorders. (full – 2011) http/

Symptom-relieving and neuroprotective effects of the phytocannabinoid D(9) -THCV in animal models of Parkinson's disease (full – 2011) http/

Cannabinoid Receptor Type 1 Protects Nigrostriatal Dopaminergic Neurons against MPTP Neurotoxicity by Inhibiting Microglial Activation. (full – 2011) http/

Cannabinoid receptor signalling in neurodegenerative diseases: a potential role for membrane fluidity disturbance. (full – 2011) http/

Endocannabinoid hydrolysis generates brain prostaglandins that promote neuroinflammation (full – 2011) http/

Therapeutic Potential of Cannabinoids in the Treatment of Neuroinflammation Associated with Parkinson's Disease (abst – 2011) http/

Regional changes in type 1 cannabinoid receptor availability in Parkinson's disease in vivo (abst – 2011) http/

Homeostatic changes of the endocannabinoid system in Parkinson's disease. (abst – 2011) http/

New metabolic pathway for controlling brain inflammation (news – 2011) http/

Scripps Research Scientists Discover Inflammation Is Controlled Differently in Brain and Other Tissues (news – 2011) http/

The dynamic nature of type 1 cannabinoid receptor (CB1) gene transcription (full - 2012) http/

The Therapeutic Potential of Cannabis and Cannabinoids (full – 2012) http/

Cannabinoid modulation of neuroinflammatory disorders. (full – 2012) http/

Review article: The endocannabinoid system in normal and pathological brain ageing (full – 2012) http/

The cannabinoid agonist WIN55212-2 decreases l-DOPA-induced PKA activation and dyskinetic behavior in 6-OHDA-treated rats. (full – 2012) http/

Cannabinoids and value-based decision making: implications for neurodegenerative disorders. (full – 2012) http/

Δ(9) -THC exerts a direct neuroprotective effect in a human cell culture model of Parkinson's disease. (abst – 2012) http/

The decrease of dopamine D(2)/D(3) receptor densities in the putamen and nucleus caudatus goes parallel with maintained levels of CB(1) cannabinoid receptors in Parkinson's disease: A preliminary autoradiographic study with the selective dopamine D(2)/D(3) antagonist [(3)H]raclopride and the novel CB(1) inverse agonist [(125)I]SD7015. (abst – 2012) http/

Contribution of genetic variants to pain susceptibility in Parkinson disease (abst – 2012) http/

Scientists find a new pharmacological target to modulate the effect of cannabinoids through their CB1 receptors (news – 2012) http/

5 Marijuana Compounds That Could Help Combat Cancer, Alzheimers, Parkinsons (If Only They Were Legal) (news – 2012) http/

Natural Cannabinoids Improve Dopamine Neurotransmission and Tau and Amyloid Pathology in a Mouse Model of Tauopathy. (full – 2013) http/

Evaluation of the role of striatal cannabinoid CB1 receptors on movement activity of parkinsonian rats induced by reserpine. (full – 2013) http/

Striatal Molecular Signature of Subchronic Subthalamic Nucleus High Frequency Stimulation in Parkinsonian Rat. (full – 2013) http/

The Influence of Cannabinoids on Generic Traits of Neurodegeneration. (full – 2013) http/

A spontaneous deletion of α-Synuclein is associated with an increase in CB1 mRNA transcript and receptor expression in the hippocampus and amygdala: Effects on alcohol consumption (abst – 2013) http/

Cannabidiol attenuates catalepsy induced by distinct pharmacological mechanisms via 5-HT1A receptors activation in mice. (abst – 2013) http/

Therapeutic Potential of Cannabinoids in Neurodegenerative Disorders: A Selective Review. (abst – 2013) http/

Δ9-Tetrahydrocannabinol is protective through PPARγ dependent mitochondrial biogenesis in a cell culture model of Parkinson’s Disease (abst – 2013) http/

Oleoylethanolamide reduces L-DOPA-induced dyskinesia via TRPV1 receptor in a mouse model of Parkinson´s disease. (abst – 2013) http/

The combination of oral L-DOPA/rimonabant for effective dyskinesia treatment and cytological preservation in a rat model of Parkinson's disease and L-DOPA-induced dyskinesia. (abst – 2013) http/

Cannabidiol Normalizes Capase 3, Synatophsin, and Mitochondrial Fission Protein DNM1L Expression Levels in Rats with Brain Iron Overload: Implications for Neuroprotection (abst – 2013) http/

Smoking Pot Eases Tremors in Parkinson's (news – 2013) http/

The endocannabinoid system: a putative role in neurodegenerative diseases. (full – 2014) http/

L-DOPA disrupts adenosine A2A-cannabinoid CB1-dopamine D2 receptor heteromer cross-talk in the striatum of hemiparkinsonian rats: Biochemical and behavioral studies. (abst – 2014) http/

Genome-wide microarray analysis identifies a potential role for striatal retrograde endocannabinoid signaling in the pathogenesis of experimental L-DOPA-induced dyskinesia. (abst – 2014) http/

Cannabis (Medical Marijuana) Treatment for Motor and Non-Motor Symptoms of Parkinson Disease: An Open-Label Observational Study. (abst – 2014) http/

Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson's disease patients: a case series. (abst – 2014) http/

The monoacylglycerol lipase inhibitor JZL184 is neuroprotective and alters glial cell phenotype in the chronic MPTP mouse model. (abst – 2014) http/

Detection of cannabinoid receptors CB1 and CB2 within basal ganglia output neurons in macaques: changes following experimental parkinsonism. (abst – 2014) http/

Effects of cannabidiol in the treatment of patients with Parkinson's disease: An exploratory double-blind trial (abst – 2014)

Identification of CB2 receptors in human nigral neurons that degenerate in Parkinson's disease (abst – 2014)

Activation of PPAR gamma receptors reduces levodopa-induced dyskinesias in 6-OHDA-lesioned rats (abst – 2014)

March 19, 2015 at 7:57 AM Flag Quote & Reply

This topic is closed, no additional posts are allowed.